Literature DB >> 2901923

Responses of plasma oxytocin and arginine vasopressin to nausea induced by apomorphine and ipecacuanha.

S S Nussey1, J Hawthorn, S R Page, V T Ang, J S Jenkins.   

Abstract

Apomorphine, a centrally-acting emetic, was administered subcutaneously (50 micrograms/kg) to nine normal subjects (four male, five female; aged 22-36 years) and four patients with idiopathic diabetes insipidus (DI) (one male, three female; aged 24-49 years). In the normal subjects this stimulus caused nausea (and vomiting in seven of nine) with a latency of 9.5 +/- 0.9 min which was followed by a large increase in plasma arginine vasopressin (AVP) concentration (from 0.9 +/- 0.2 pmol/l to 249 +/- 104 pmol/l at 15 min after the onset of symptoms; mean +/- SEM, P less than 0.01). There was a small but significant increase in plasma oxytocin (OXT) concentration (from 1.6 +/- 0.4 pmol/l to 6.2 +/- 3.4 pmol/l; P less than 0.05). Mean arterial pressure (MAP) fell slightly (from 87 +/- 1.9 mm Hg to 71 +/- 4.4 mm Hg; P less than 0.05) 15 min after the onset of nausea; there was no change in blood haematocrit or plasma osmolality and sodium concentration. In the DI patients apomorphine produced nausea (with vomiting in three of four) with a latency of 10.0 +/- 1.4 min but failed to cause an increase in either plasma AVP or OXT. In the DI patients the fall in MAP did not reach statistical significance (83 +/- 4 mm Hg to 71 +/- 11 mm Hg); there was also no change in haematocrit, osmolality or sodium concentration. Ipecacuanha, an emetic with both peripheral and central actions, was administered orally to seven normal subjects (three male, four female; aged 22-36 years) six of whom also underwent apomorphine tests.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901923     DOI: 10.1111/j.1365-2265.1988.tb01216.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.

Authors:  Kai Macdonald; David Feifel
Journal:  Acta Neuropsychiatr       Date:  2011-12-19       Impact factor: 3.403

2.  Raised plasma arginine vasopressin concentrations during cluster headache attacks.

Authors:  R Franceschini; M Leandri; A Cataldi; E Bruno; G Corsini; E Rolandi; T Barreca
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-10       Impact factor: 10.154

Review 3.  Physiology of chemotherapy-induced emesis and antiemetic therapy. Predictive models for evaluation of new compounds.

Authors:  C Veyrat-Follet; R Farinotti; J L Palmer
Journal:  Drugs       Date:  1997-02       Impact factor: 9.546

Review 4.  What is nausea? A historical analysis of changing views.

Authors:  Carey D Balaban; Bill J Yates
Journal:  Auton Neurosci       Date:  2016-07-16       Impact factor: 3.145

Review 5.  Opportunities for the replacement of animals in the study of nausea and vomiting.

Authors:  A M Holmes; J A Rudd; F D Tattersall; Q Aziz; P L R Andrews
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

6.  Abnormal baroreceptor-mediated vasopressin release as possible marker in early diagnosis of multiple system atrophy.

Authors:  K Deguchi; I Sasaki; T Touge; M Tsukaguchi; H Takeuchi; S Kuriyama
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-01       Impact factor: 10.154

Review 7.  Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases.

Authors:  Paul L R Andrews; Charles C Horn
Journal:  Auton Neurosci       Date:  2006-03-23       Impact factor: 3.145

Review 8.  The role of the parasympathetic nervous system in visually induced motion sickness: systematic review and meta-analysis.

Authors:  Adam D Farmer; Yasser Al Omran; Qasim Aziz; Paul L Andrews
Journal:  Exp Brain Res       Date:  2014-05-04       Impact factor: 1.972

Review 9.  The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis.

Authors:  Elizabeth A Lawson; Pawel K Olszewski; Aron Weller; James E Blevins
Journal:  J Neuroendocrinol       Date:  2019-11-28       Impact factor: 3.627

10.  Arginine vasopressin--a mediator of chemotherapy induced emesis?

Authors:  C M Edwards; J Carmichael; P H Baylis; A L Harris
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.